Methylpyrrolidone

Methylpyrrolidone

SCHEMBL1801243

CC(=O)O.CN1CCCC1=O

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Methylpyrrolidone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.77
BRD2 P25440 1/20 0.77
LMNA P02545 2/20 0.42
ALDH1A1 P00352 3/20 0.40
KMT2A Q03164 4/20 0.40
TSHR P16473 1/20 0.39
INMT O95050 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA3 P07451 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA13 Q8N1Q1 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
PIK3CD O00329 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylpyrrolidone SCHEMBL28608007 0.98 BRD4 (0.74) BRD4BRD2LMNAALDH1A1KMT2A
Methylpyrrolidone SCHEMBL28884394 0.98 BRD4 (0.74) BRD4BRD2LMNAALDH1A1KMT2A
Methylpyrrolidone SCHEMBL10701586 0.93 BRD4 (0.81) BRD4BRD2LMNAALDH1A1KMT2A
Methylpyrrolidone SCHEMBL2243830 0.93 BRD4 (0.81) BRD4BRD2LMNAALDH1A1KMT2A
Methylpyrrolidone SCHEMBL28866005 0.91 BRD4 (0.77) BRD4BRD2LMNAALDH1A1KMT2A
Methylpyrrolidone SCHEMBL28525083 0.91 BRD4 (0.77) BRD4BRD2LMNAALDH1A1KMT2A
Methylpyrrolidone SCHEMBL6251574 0.89 BRD4 (0.74) BRD4BRD2LMNAALDH1A1KMT2A
Methylpyrrolidone SCHEMBL1368701 0.88
Methylpyrrolidone SCHEMBL5423326 0.88
Methylpyrrolidone SCHEMBL8055062 0.88 BRD4 (1.00) BRD4BRD2LMNAALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1121273-C Double metal cyanide catalysts contg. cyclic, bidentate complexing agent BAYER ANTWERPEN NV (BE) 2003-09-17 CN claimed
US-6488730-B2 Polishing composition CHEIL INDUSTRIES, INC. (KR) 2002-12-03 US claimed
US-20020022369-A1 Polishing composition CHEIL INDUSTRIES, INC. (KR) 2002-02-21 US claimed
CN-1309587-A Double metal cyanide catalysts contg. cyclic, bidentate complexing agent BAYER ANTWERPEN NV (BE) 2001-08-22 CN claimed
CN-118459387-A Piracetam preparation method 湖南赛隆药业(长沙)有限公司 2024-08-09 CN disclosed
CN-117999475-A Electrochemical gas sensor and electrolyte for electrochemical gas sensor 德尔格安全股份两合公司 2024-05-07 CN disclosed
CN-115845812-B Preparation method and application of magnetic lignin adsorption material 大连工业大学 2024-05-03 CN disclosed
CN-111247182-B Block copolymer, dispersant, coloring composition, and color filter 大塚化学株式会社 2023-08-22 CN disclosed
CN-116574045-A Preparation method of piracetam raw material 河北龙海药业有限公司 2023-08-11 CN disclosed
CN-115845812-A Preparation method and application of magnetic lignin adsorption material 大连工业大学 2023-03-28 CN disclosed
CN-111094373-B Two-component system for elastomeric coatings 科思创德国股份有限公司 2022-11-29 CN disclosed
CN-111971116-B Dispersant composition, coloring composition and color filter 大塚化学株式会社 2022-06-28 CN disclosed
EP-0541654-A1 BOMBESIN ANTAGONISTS THE WELLCOME FOUNDATION LIMITED (GB) 1993-05-19 EP disclosed
EP-0522082-A1 MULTI-FUNCTIONAL PHARMACEUTICAL COMPOUNDS AND METHODS OF USE. GLASKY ALVIN J (US) 1993-01-13 EP disclosed
US-5091432-A Synergistic SPECTRUM PHARMACEUTICALS, INC. 1992-02-25 US disclosed
WO-1992002545-A1 BOMBESIN ANTAGONISTS THE WELLCOME FOUNDATION LIMITED (GB) 1992-02-20 WO disclosed
WO-1991014434-A1 MULTI-FUNCTIONAL PHARMACEUTICAL COMPOUNDS AND METHODS OF USE GLASKY ALVIN J (US) 1991-10-03 WO disclosed
EP-0427636-A2 4-Acylaminopyridine derivatives Mitsubishi Chemical Corporation (JP) 1991-05-15 EP disclosed
US-4985430-A ALZHEIMER*S DISEASE MITSUBISHI KASEI CORPORATION (JP) 1991-01-15 US disclosed
EP-0319429-A2 9-Acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient MITSUBISHI KASEI CORPORATION (JP) 1989-06-07 EP disclosed